IBA to acquire full interest in CIS Bio

Belgian radiopharmaceutical firm Ion Beam Applications (IBA) plans to expand its stake in French biomedical technology company CIS Bio International to own 100% of the company.

IBA currently owns 20% of CIS Bio, with the rest of the company owned by IRE (Institut National des Radioéléments) of Fleurus, Belgium. IBA and IRE bought their stakes in CIS Bio from German pharmaceutical company Schering (now Bayer Schering Pharma of Berlin) in 1996.

Terms of the buyout are under negotiation and should be finalized in the first half of 2008, Louvain-la-Neuve-based IBA said. The price is expected to be 20 million euros ($27.7 million), to be paid in cash and IBA shares.

By AuntMinnie.com staff writers
September 14, 2007

Related Reading

IBA buries proton hatchet with Optivus, Loma Linda, August 21, 2007

IBA to equip fourth U.S. proton therapy center, July 25, 2007

IBA gets OK for U.K. PET facility, July 3, 2007

IBA opens Beijing office, June 18, 2007

IBA begins European I-124 shipments, June 4, 2007

Copyright © 2007 AuntMinnie.com

Page 1 of 594
Next Page